Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxaliplatin: a review of evolving concepts.

Literature DB >> 11901545

Oxaliplatin: a review of evolving concepts.

Sridhar Mani¹, Martin A Graham, David B Bregman, Percy Ivy, Stephen G Chaney.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2002 PMID： 11901545 DOI： 10.1081/cnv-120001152

Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors: C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal: Cancer Chemother Pharmacol Date: 2011-10-04 Impact factor: 3.333

Review 2. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.

Authors: Loek A W de Jong; Fortuné M K Elekonawo; Philip R de Reuver; Andre J A Bremers; Johannes H W de Wilt; Frank G A Jansman; Rob Ter Heine; Nielka P van Erp
Journal: Br J Clin Pharmacol Date: 2018-10-25 Impact factor: 4.335

3. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin.

Authors: Linlin Wu; Changjun Man; Hong Wang; Xiaohe Lu; Qinghai Ma; Yu Cai; Wanshan Ma
Journal: Pharm Res Date: 2012-09-20 Impact factor: 4.200

4. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

Authors: Elin Jerremalm; Mikael Hedeland; Inger Wallin; Ulf Bondesson; Hans Ehrsson
Journal: Pharm Res Date: 2004-05 Impact factor: 4.200

Oxaliplatin: a review of evolving concepts.

1. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Review 2. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.

3. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin.

4. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

5. Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14^ARF-Mediated Sustained p53 Activation.

6. Oxaliplatin and its enantiomer induce different condensation dynamics of single DNA molecules.

7. Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.

8. Oxaliplatin neurotoxicity--no general ion channel surface-charge effect.

9. Platinum-containing regimens for triple-negative metastatic breast cancer.

Review 10. Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma.